Nasenien Nourkami‐Tutdibi

Circulating serum miRNAs as potential biomarkers for nephroblastoma

Nicole Ludwig, Nasenien Nourkami‐Tutdibi, Christina Backes et al. · Pediatric Blood & Cancer · 2015 · 63 citations

<i>ETV6</i>–<i>NTRK3</i> in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study

Christian Vokuhl, Nasenien Nourkami‐Tutdibi, Rhoikos Furtwängler et al. · Pediatric Blood & Cancer · 2017 · 56 citations

Long-Term Knowledge Retention after Peer-Assisted Abdominal Ultrasound Teaching: Is PAL a Successful Model for Achieving Knowledge Retention?

Nasenien Nourkami‐Tutdibi, Erol Tutdibi, Susanne Schmidt et al. · Ultraschall in der Medizin - European Journal of Ultrasound · 2019 · 51 citations

High‐dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival—The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience

Rhoikos Furtwängler, Leo Kager, Patrick Melchior et al. · Pediatric Blood & Cancer · 2017 · 48 citations

Treatment-independent miRNA signature in blood of wilms tumor patients

J. Schmitt, Christina Backes, Nasenien Nourkami‐Tutdibi et al. · BMC Genomics · 2012 · 34 citations · Full text